Literature DB >> 22499457

Representations and practices of prevention in elderly populations: investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer's disease (ACCEPT study)--the need for a multidisciplinary approach.

S Andrieu1, N Coley, V Gardette, J Subra, S Oustric, T Fournier, J-P Poulain, D Coniasse-Brioude, V Igier, B Vellas, A Grand.   

Abstract

BACKGROUND: In the domain of Alzheimer's disease (AD) prevention, various potentially protective factors have been identified in epidemiological studies. Although the results of these observational studies have been relatively consistent, the results of intervention studies remain disappointing. Methodological problems could explain these negative results, like the selection of the population; a plausible assumption is that the older people who agree to take part in these intervention studies differ from those who refuse, and are those that are least likely to benefit from such programs. The aim of this study was (i) to study the determinants of participation in and adhesion to a prevention trial in a population of older individuals via a quantitative approach using a questionnaire, (ii) to study the representations and practices of prevention in this population using a qualitative approach using semi-structured interviews and focus groups.
METHOD: The study population for the ACCEPT study was recruited at the time of inclusion of subjects in a prevention trial. The population was made up of persons aged 70 years or older, living at home and demonstrating some form of frailty, defined as a spontaneous memory complaint to their general practitioner or difficulties in carrying out instrumental activities of daily living. We used a quantitative approach based on the administration of a self-completed questionnaire sent to 1680 subjects having accepted to take part in the prevention trial, and to the sample of subjects meeting the inclusion criteria but having refused to take part. The qualitative approach, carried out at the moment of inclusion, involved subjects that having accepted to take part and subjects that having refused. Semi-structured interviews were carried out in order to understand the logic leading to refusal or acceptance.
CONCLUSION: The analysis of the results will combine the viewpoints of the different disciplines. It will allow us to better understand the logic at work, to characterise the populations at risk of refusal, and perhaps to remove some of the barriers to participation in prevention programs. The identification of such barriers will provide feedback in terms of the conception and management of prevention measures.

Entities:  

Mesh:

Year:  2012        PMID: 22499457     DOI: 10.1007/s12603-012-0045-9

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  27 in total

1.  Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience.

Authors:  Annette L Fitzpatrick; Linda P Fried; Jeff Williamson; Patricia Crowley; Delilah Posey; Linly Kwong; Janet Bonk; Roberta Moyer; Joyce Chabot; Lara Kidoguchi; Curt D Furberg; Steven T DeKosky
Journal:  Contemp Clin Trials       Date:  2006-07-04       Impact factor: 2.226

2.  Social network characteristics and cognition in middle-aged and older adults.

Authors:  Ronald E Holtzman; George W Rebok; Jane S Saczynski; Anthony C Kouzis; Kathryn Wilcox Doyle; William W Eaton
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2004-11       Impact factor: 4.077

Review 3.  Medications and diet: protective factors for AD?

Authors:  Claudia H Kawas
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jul-Sep       Impact factor: 2.703

4.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Authors:  M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

Review 5.  Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients.

Authors:  J M Bourre
Journal:  J Nutr Health Aging       Date:  2006 Sep-Oct       Impact factor: 4.075

6.  Mediterranean diet, Alzheimer disease, and vascular mediation.

Authors:  Nikolaos Scarmeas; Yaakov Stern; Richard Mayeux; Jose A Luchsinger
Journal:  Arch Neurol       Date:  2006-10-09

7.  Social resources and cognitive decline in a population of older African Americans and whites.

Authors:  L L Barnes; C F Mendes de Leon; R S Wilson; J L Bienias; D A Evans
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

8.  Factors influencing the participation of older people in clinical trials - data analysis from the MAVIS trial.

Authors:  P Fearn; A Avenell; S McCann; A C Milne; G Maclennan
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

9.  Exercise level and cognitive decline: the MoVIES project.

Authors:  Mary Ellen Lytle; Joni Vander Bilt; Rajesh S Pandav; Hiroko H Dodge; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Apr-Jun       Impact factor: 2.703

10.  Randomized intervention trial on preventive home visits to older people: baseline and follow-up characteristics of participants and non-participants.

Authors:  Mikkel Vass; Kirsten Avlund; Carsten Hendriksen
Journal:  Scand J Public Health       Date:  2007       Impact factor: 3.021

View more
  6 in total

1.  The role of 'modified Mediterranean diet' and quantum therapy in Alzheimer's disease primary prevention.

Authors:  M Marchionni; S Stagnaro; S Caramel
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

Review 2.  Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.

Authors:  Mercè Boada; Miguel A Santos-Santos; Octavio Rodríguez-Gómez; Montserrat Alegret; Pilar Cañabate; Asunción Lafuente; Carla Abdelnour; Mar Buendía; Maria José de Dios; América Morera; Ángela Sanabria; Laura Campo; Agustín Ruiz; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Experiences of dementia and attitude towards prevention: a qualitative study among older adults participating in a prevention trial.

Authors:  Anna Rosenberg; Nicola Coley; Alexandra Soulier; Jenni Kulmala; Hilkka Soininen; Sandrine Andrieu; Miia Kivipelto; Mariagnese Barbera
Journal:  BMC Geriatr       Date:  2020-03-12       Impact factor: 3.921

4.  Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial.

Authors:  Nicola Coley; Delphine Coniasse-Brioude; Valérie Igier; Tristan Fournier; Jean-Pierre Poulain; Sandrine Andrieu
Journal:  Alzheimers Res Ther       Date:  2021-09-24       Impact factor: 6.982

5.  Optimization of the inclusion of Alzheimer's disease patients in international multicenter randomized trials: results of a national survey conducted in memory research centers in france.

Authors:  A E Tchalla; C Adam; C Gayot; P Cowppli-Bony; P M Preux; T Dantoine
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-11-01

6.  Attitudes of at-risk older adults about prevention of cardiovascular disease and dementia using eHealth: a qualitative study in a European context.

Authors:  Ulrika Akenine; Mariagnese Barbera; Cathrien Rl Beishuizen; Mandana Fallah Pour; Juliette Guillemont; Anna Rosenberg; Nicola Coley; Francesca Mangialasche; Lotta Salo; Stephanie Savy; A Jeannette Pols; Sandrine Andrieu; Edo Richard; Hilkka Soininen; Eric Moll van Charante; Miia Kivipelto
Journal:  BMJ Open       Date:  2020-08-06       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.